SCNI
Scinai Immunotherapeutics
SCNI
SCNI
18 hedge funds and large institutions have $544K invested in Scinai Immunotherapeutics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
State Street
Boston,
Massachusetts
|
$0 |
2 |
ECM
2
ExodusPoint Capital Management
New York
|
$0 |
3 |
TSS
3
Two Sigma Securities
New York
|
$38K |
4 |
![]()
4
JPMorgan Chase & Co
New York
|
$0 |